PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-11-01

Date Title Company
01-Nov-2023 Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress Businesswire
01-Nov-2023 Aptatek BioSciences, Inc. Appoints Seasoned Healthcare Executive Lee McCracken to its Board of Directors Businesswire
01-Nov-2023 Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023 Businesswire
01-Nov-2023 Fabric Genomics and DNAnexus Team Up to Improve Scale and Speed of Data Analysis for Genomic Medicine Businesswire
01-Nov-2023 Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 Businesswire
01-Nov-2023 Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million Businesswire
01-Nov-2023 Vibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia (CLTI) Businesswire
01-Nov-2023 Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed Businesswire
01-Nov-2023 NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support NorthX Biologics AB
01-Nov-2023 Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors Anaveon
01-Nov-2023 ViroCell and Great Ormond Street Hospital poised to unlock clinical trial ‘backlog’ following MHRA manufacturing approval ViroCell Biologics
01-Nov-2023 Aragen setting up a $ 30 million bio-manufacturing site in India Aragen
01-Nov-2023 Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap Businesswire
01-Nov-2023 Antibe Completes First Clinical Study of Otenaproxesul’s New Formulation Businesswire
01-Nov-2023 Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment Businesswire
01-Nov-2023 Can-Fite Issues Business Update: All Clinical Programs and Business Development Activities Remain Solidly on Track Businesswire
01-Nov-2023 IQVIA Reports Third-Quarter 2023 Results Businesswire
01-Nov-2023 Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease Businesswire
01-Nov-2023 Bioluminescence Ventures Emerges from Stealth with $477M AUM Businesswire
01-Nov-2023 Merck to Participate in the UBS BioPharma Conference Businesswire